Home monitoring for wet AMD using a webcam
Part of Eyes & vision clinical trials.
This study tests a home monitoring system using a webcam to check for signs of wet AMD returning. It may help you manage your condition between doctor visits and catch problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 99 years old.
- You are currently being treated for wet age-related macular degeneration (wet AMD).
- You do not have any signs of active AMD (like new fluid or bleeding in the eye) at the start of the study.
- You can understand spoken instructions in English, Chinese, or Malay.
- You can turn on a computer and connect a webcam by yourself or with help from a family member.
- You have not had eye surgery in the last 3 months or a vitrectomy in the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a web-based system that uses eye tracking to check vision in people being treated for wet age-related macular degeneration (AMD). It may help monitor your recovery without needing as many clinic visits.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
This study looks at eye fluid from people with untreated wet AMD to find out why some don't respond well to standard injections. The goal is to improve future treatments.
This trial tests a home monitoring app (OKKO Health) for people with wet age-related macular degeneration (AMD). It aims to see if using the app helps track the disease and guide treatment decisions by your doctor.
This study tests a new AI-powered camera that takes special pictures of the back of the eye to find signs of wet age-related macular degeneration (AMD) more easily. It compares images from people with wet AMD and healthy volunteers to see if the AI can spot the disease early.
This study uses a special camera to take pictures of the back of your eye (retina) to see how age-related macular degeneration (AMD) affects everyday activities like reading and recognizing faces. It also compares people with AMD to healthy volunteers to understand the differences.
Hear when a new Maculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.